These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15596916)

  • 21. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.
    Engstrom PF; Lavin PT; Moertel CG; Folsch E; Douglass HO
    J Clin Oncol; 1984 Nov; 2(11):1255-9. PubMed ID: 6238136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer.
    Park JO; Chung HC; Cho JY; Rha SY; You NC; Kim JH; Noh SH; Kim CB; Min JS; Kim BS; Roh JK
    Am J Clin Oncol; 1997 Oct; 20(5):484-9. PubMed ID: 9345333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen.
    Yoo C; Kim BJ; Kim KP; Lee JL; Kim TW; Ryoo BY; Chang HM
    Cancer Res Treat; 2017 Jul; 49(3):759-765. PubMed ID: 27857025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy.
    Shibuya H; Hijioka S; Sakamoto Y; Ito T; Ueda K; Komoto I; Kobayashi N; Kudo A; Yasuda H; Miyake H; Arita J; Kiritani S; Ikeda M; Imaoka H; Ueno M; Kobayashi S; Furuta M; Nagashio Y; Murohisa G; Aoki T; Matsumoto S; Motoya M; Azemoto N; Itakura J; Horiguchi S; Yogi T; Kawagoe T; Miyaoka Y; Imamura F; Senju M; Arioka H; Hara K; Imamura M; Okusaka T
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):661-668. PubMed ID: 30054710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended cycle streptozotocin/5-FU chemotherapy for maintenance therapy in pancreatic neuroendocrine tumors.
    Schrader J; Henes FO; Blaeker M; Zimmermann-Fraedrich K; Pace A; Perez D; Izbicki JR; Lohse AW; Benten D
    Endocrine; 2019 Aug; 65(2):460-467. PubMed ID: 31037707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
    Frame J; Kelsen D; Kemeny N; Cheng E; Niedzwiecki D; Heelan R; Lippermann R
    Am J Clin Oncol; 1988 Aug; 11(4):490-5. PubMed ID: 2841843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
    Oster MW; Gray R; Panasci L; Perry MC
    Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase-II study of liposomal doxorubicin and docetaxel in patients with advanced pancreatic cancer.
    Syrigos KN; Michalaki B; Alevyzaki F; Machairas A; Mandrekas D; Kindilidis K; Karatzas G
    Anticancer Res; 2002; 22(6B):3583-8. PubMed ID: 12552960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy in the treatment of neuroendocrine malignant tumors.
    Rougier P; Mitry E
    Digestion; 2000; 62 Suppl 1():73-8. PubMed ID: 10940691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation and chemotherapy. Treatment of localized pancreatic carcinoma.
    Blitzer PH; Dosoretz DE; Katin MJ; Rubenstein JH; Harwin WN; Raymond MG; Teufel TE; Seidenstein L; Mangano MM; Salenius SA
    J Fla Med Assoc; 1994 Jun; 81(6):403-7. PubMed ID: 8064281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective, randomized Phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma.
    Blajman C; Balbiani L; Block J; Coppola F; Chacon R; Fein L; Bonicatto S; Alvarez A; Schmilovich A; Delgado FM
    Cancer; 1999 Mar; 85(5):1091-7. PubMed ID: 10091793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity.
    Clewemar Antonodimitrakis P; Sundin A; Wassberg C; Granberg D; Skogseid B; Eriksson B
    Neuroendocrinology; 2016; 103(3-4):345-53. PubMed ID: 26279284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE).
    Roquin G; Baudin E; Lombard-Bohas C; Cadiot G; Dominguez S; Guimbaud R; Niccoli P; Legoux JL; Mitry E; Rohmer V; Ruszniewski P; Walter T; Ducreux M; Couvelard A; Scoazec JY; Ramond-Roquin A; Caroli-Bosc FX; Hentic O
    Neuroendocrinology; 2018; 106(1):38-46. PubMed ID: 28152531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
    Nocera M; Baudin E; Pellegriti G; Cailleux AF; Mechelany-Corone C; Schlumberger M
    Br J Cancer; 2000 Sep; 83(6):715-8. PubMed ID: 10952773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity and safety of vinorelbine combined with doxorubicin or fluorouracil as first-line therapy in advanced breast cancer: a stratified phase II study.
    Hochster HS; Vogel CL; Burman SL; White R
    Oncologist; 2001; 6(3):269-77. PubMed ID: 11423674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential high-dose methotrexate, 5-fluorouracil, and doxorubicin for treatment of advanced pancreatic cancer.
    Scheithauer W; Funovics J; Mueller C; Ludwig H
    J Cancer Res Clin Oncol; 1990; 116(2):132-3. PubMed ID: 2324155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
    Wang X; Pang L; Feng J
    Am J Clin Oncol; 2002 Feb; 25(1):71-5. PubMed ID: 11823701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metastatic pancreatic neuroendocrine tumors and chemotherapy: evidences and perspectives].
    Gómez Raposo C; Gómez Senent S; González Barón M
    Med Clin (Barc); 2007 Mar; 128(9):357; author reply 357-8. PubMed ID: 17376367
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy of advanced pancreatic cancer with 5-fluorouracil, doxorubicin and high-dose methotrexate].
    Scheithauer W; Ludwig H; Zielinski C; Funovics J; Knoflach P; Müller C; Grabner G
    Leber Magen Darm; 1988 Jun; 18(3):149-55. PubMed ID: 3043129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.